Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma
Clinical trial NCT06764537 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06764537
- Sponsor
- Central Hospital, Nancy, France
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2027-01-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.